Paper37762008
Activation of G-Protein-Coupled Estrogen Receptor 1 (GPER1) Reduces Progression of Vulvar Carcinoma Cells.
Loris J and 4 others. Int J Mol Sci, 2023. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Activation of G-Protein-Coupled Estrogen Receptor 1 (GPER1) Reduces Progression of Vulvar Carcinoma Cells. Papers, record 37762008. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37762008
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Activation of G-Protein-Coupled Estrogen Receptor 1 (GPER1) Reduces Progression of Vulvar Carcinoma Cells.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma | Major topic |
| Receptors, Estrogen | Major topic |
| Receptors, G-Protein-Coupled | Major topic |
| Vulvar Neoplasms | Major topic |
| Female | |
| Humans | |
| Estrogen Receptor alpha | |
| GTP-Binding Proteins |
Source PubMed
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29239277 | Nuclear G protein-coupled oestrogen receptor (GPR30) predicts poor survival in patients with ovarian cancer. | J Int Med Res | 2018 | https://conductscience.org/library/papers/29239277 | PubMed |
| 2 | 26175858 | G15 sensitizes epithelial breast cancer cells to doxorubicin by preventing epithelial-mesenchymal transition through inhibition of GPR30. | Am J Transl Res | 2015 | https://conductscience.org/library/papers/26175858 | PubMed |
| 3 | 33707570 | Four-decade trends in lymph node status of patients with vulvar squamous cell carcinoma in northern Italy. | Sci Rep | 2021 | https://conductscience.org/library/papers/33707570 | PubMed |
| 4 | 33117280 | Continuous Exposure of Breast Cancer Cells to Tamoxifen Upregulates GPER-1 and Increases Cell Proliferation. | Front Endocrinol (Lausanne) | 2020 | https://conductscience.org/library/papers/33117280 | PubMed |
| 5 | 23145207 | The putative G-protein coupled estrogen receptor agonist G-1 suppresses proliferation of ovarian and breast cancer cells in a GPER-independent manner. | Am J Transl Res | 2012 | https://conductscience.org/library/papers/23145207 | PubMed |
| 6 | 27107933 | The G protein-coupled estrogen receptor as a modulator of neoplastic transformation. | Mol Cell Endocrinol | 2016 | https://conductscience.org/library/papers/27107933 | PubMed |
| 7 | 31483053 | Elevated expression of G protein-coupled receptor 30 (GPR30) is associated with poor prognosis in patients with uterine cervical adenocarcinoma. | Histol Histopathol | 2020 | https://conductscience.org/library/papers/31483053 | PubMed |
| 8 | 30227306 | Estrogen/GPR30 Signaling Contributes to the Malignant Potentials of ER-Negative Cervical Adenocarcinoma via Regulation of Claudin-1 Expression. | Neoplasia | 2018 | https://conductscience.org/library/papers/30227306 | PubMed |
| 9 | 24314615 | Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study. | Lancet Oncol | 2014 | https://conductscience.org/library/papers/24314615 | PubMed |
| 10 | 24161432 | G15, a GPR30 antagonist, induces apoptosis and autophagy in human oral squamous carcinoma cells. | Chem Biol Interact | 2013 | https://conductscience.org/library/papers/24161432 | PubMed |
| 11 | 20658519 | Crossing barriers: the new dimension of 2D cell migration assays. | J Cell Physiol | 2011 | https://conductscience.org/library/papers/20658519 | PubMed |
| 12 | 11140706 | Validation of tissue microarray technology in breast carcinoma. | Lab Invest | 2000 | https://conductscience.org/library/papers/11140706 | PubMed |
| 13 | 26433678 | Cancer of the vulva. | Int J Gynaecol Obstet | 2015 | https://conductscience.org/library/papers/26433678 | PubMed |
| 14 | 21192171 | Clinical and pathologic features of vulvar intraepithelial neoplasia in premenopausal and postmenopausal women. | J Low Genit Tract Dis | 2011 | https://conductscience.org/library/papers/21192171 | PubMed |
| 15 | 30727915 | GPER Overexpression in Cervical Cancer Versus Premalignant Lesions: Its Activation Induces Different Forms of Cell Death. | Anticancer Agents Med Chem | 2019 | https://conductscience.org/library/papers/30727915 | PubMed |
| 16 | 21782022 | Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivity. | J Steroid Biochem Mol Biol | 2011 | https://conductscience.org/library/papers/21782022 | PubMed |
| 17 | 26527320 | Tumorsphere as an effective in vitro platform for screening anti-cancer stem cell drugs. | Oncotarget | 2016 | https://conductscience.org/library/papers/26527320 | PubMed |
| 18 | 31611744 | Estrogen receptor subtype agonist activation in human cutaneous squamous cell carcinoma cells modulates expression of CD55 and Cyclin D1. | EXCLI J | 2019 | https://conductscience.org/library/papers/31611744 | PubMed |
| 19 | 8812536 | Epidemiologic data on vulvar cancer: comparison of hospital with population-based data. | Gynecol Oncol | 1996 | https://conductscience.org/library/papers/8812536 | PubMed |
| 20 | 19591047 | Dose-dependent inhibition of BrdU detection in the cell proliferation ELISA by culture medium proteins. | J Immunoassay Immunochem | 2009 | https://conductscience.org/library/papers/19591047 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42379802 | Inhibition of Plasminogen Activator Inhibitor-1 (PAI-1) by Tiplaxtinin Attenuates the Aggressive Phenotype of Vulvar Squamous Cell Carcinoma Cells In Vitro. | In Vivo | 2026 | https://conductscience.org/library/papers/42379802 | PubMed |
| 41586754 | Overexpression of GPER1 suppressed esophageal carcinoma growth via activating cAMP pathway. | Eur J Histochem | 2026 | https://conductscience.org/library/papers/41586754 | PubMed |
| 40280717 | Expression of "Hallmarks of Cancer" Genes in Cervical Carcinoma Is Differentially Affected by GPER1 Overexpression Depending on Histologic Entity. | Cancer Genomics Proteomics | 2025 | https://conductscience.org/library/papers/40280717 | PubMed |
| 39730177 | G Protein-coupled Estrogen Receptor 1 (GPER1) Regulates Expression of SERPINE1/PAI-1 and Inhibits Tumorigenic Potential of Cervical Squamous Cell Carcinoma Cells In Vitro. | Cancer Genomics Proteomics | 2025 | https://conductscience.org/library/papers/39730177 | PubMed |
| 39467628 | Suppressing Expression of SERPINE1/PAI1 Through Activation of GPER1 Reduces Progression of Vulvar Carcinoma. | Cancer Genomics Proteomics | 2024 | https://conductscience.org/library/papers/39467628 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| EGFR | 1956 | PubTator's text mining | https://conductscience.org/library/genes/1956 | NCBI Gene |
| ESR1 | 2099 | PubTator's text mining | https://conductscience.org/library/genes/2099 | NCBI Gene |
| ESR2 | 2100 | PubTator's text mining | https://conductscience.org/library/genes/2100 | NCBI Gene |
| FOXO3 | 2309 | PubTator's text mining | https://conductscience.org/library/genes/2309 | NCBI Gene |
| GAPDH | 2597 | PubTator's text mining | https://conductscience.org/library/genes/2597 | NCBI Gene |
| GPER1 | 2852 | PubTator's text mining | https://conductscience.org/library/genes/2852 | NCBI Gene |
| HOTAIR | 100124700 | PubTator's text mining | https://conductscience.org/library/genes/100124700 | NCBI Gene |
| TF | 7018 | PubTator's text mining | https://conductscience.org/library/genes/7018 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37762008
GET https://conductscience.org/api/papers/v1/37762008/references?page=2